RedHill Biopharma Ltd., a specialty biopharmaceutical company primarily focused on the development and commercialization of proprietary drugs for the treatment of gastrointestinal diseases, today announced that the U.S. Food and Drug Administration (FDA) has approved Talicia® (omeprazole magnesium, amoxicillin and rifabutin) delayed-release capsules 10 mg1/250 mg/12.5 mg for the treatment of Helicobacter pylori (H. pylori)… Read More
UTHSC In the Media
The world of sickle cell research paid quiet homage Friday to Memphis entrepreneur and civic leader Frank M. Norfleet. Instead of endowing a university research chair or a hospital wing, he left money when he died in 2012 to bring researchers here every year to discuss big issues in medicine. This year’s one-day Norfleet Forum… Read More
Dr. Qi Zhao is a data epidemiologist. Her lab is her small office in the University of Tennessee Health Science Center doctors’ office building on North Pauline, where these days she’s crunching realms of data on the grip strength of people in their 60s and the speed of their gait, and then cross-referencing it with… Read More
Bay Area Lyme Foundation, a leading sponsor of Lyme disease research in the U.S., today announced that a study published in the Journal of Clinical Microbiology reports a potential new diagnostic, mChip-Ld, which can be performed in 15 minutes in a physician’s office, offers efficacy improvement over the current gold standard diagnostic, the two-tier test,… Read More
Satya Surbhi, PhD, assistant professor of Medicine in the Center for Health System Improvement at the University of Tennessee Health Science Center (UTHSC), received a $100,000 grant from the Pharmaceutical Research and Manufacturers of America Foundation to pursue research in improving medication adherence for low-income Tennessee Medicaid users.
A number of medical and surgical oncologists in the Memphis area who specialize in breast cancer say they believe local healthcare systems and cancer centers have moved a step closer to improving cure rates because of the recent addition of new technologies, surgical techniques, partnerships and market-approved medications.
St. Jude Children’s Research Hospital has won a national contract to create a flu vaccine that will be as effective for people with underlying conditions, including obesity, as the healthy. “It’s going to be a challenge,” said Dr. Chasity Shelton, assistant dean in the University of Tennessee Health Science Center’s College of Pharmacy. “The researchers… Read More
In a world of rising opioid addiction, vaping and oral cancers, 2019 is the year of oral health, says Rear Admiral Timothy Ricks, both the chief dental officer of the U.S. Public Health Service and the nation’s assistant surgeon general.